QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
-43.44%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(-51%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$601M
| $28.9M | 27.11% | 2,932,606 | – | – |
|
|
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $24.7M | 23.22% | 3,510,228 | – | – |
|
3
Jasper Therapeutics
JSPR
$45.5M
| $20.8M | 19.52% | 5,852,982 | – | – |
|
4
Kezar Life Sciences
KZR
$28.9M
| $13.8M | 12.94% | 828,711 | – | – |
|
5
Ventyx Biosciences
VTYX
$171M
| $12.4M | 11.6% | 910,306 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $5.97M | 5.61% | 2,370,142 | – | – |
|